期刊文献+

急性心肌梗死后合并心源性休克的相关危险因素分析 被引量:6

The Risk Factors for Cardiogenic Shock after Acute Myocardial Infarction in Chinese Patients
暂未订购
导出
摘要 [目的]从急性心肌梗死(acute myocardial infarction,AMI)患者中筛选出心源性休克(cardiogenic shock,CS)的相关危险因素,为临床医生和预防医学工作者提供参考依据。[方法]以1994~2004年中山大学和昆明医学院两所附属医院的2173例ST段抬高型AMI患者为研究对象,以是否发生CS为应变量,以患者的病史、性别、年龄、家族史、生活习惯和入院时的体检指标、治疗情况等指标为自变量,建立logistic回归模型,从而筛选出与CS密切相关的有价值的临床指标。[结果]年龄、性别、体重指数、心功能分级、心梗部位、外周动脉疾病、既往心梗病史、心血管病家族史,以及不接受溶栓治疗是与CS相关的9项危险因素。有心血管病家族史者发生CS的风险比无心血管病家族史者升高约43倍。未接受溶栓以及溶栓不成功者发生CS的可能性比溶栓成功者高15倍。在溶栓成功者中,41%的人在症状发作后6h内接受溶栓治疗;而在溶栓不成功者中,56%的人在症状发作超过12h才开始溶栓。[结论]AMI症状发作后早期接受溶栓治疗能大大减少CS的发生,早期溶栓治疗可作为中国老年人群CS第三级预防的一个有效手段。 [ Objective ] To detect the risk factors for cardiogenic shock ( CS ) after acute myocardial infarction( AMI ) among Chinese patients so as to guide physicians and public health professionals to prevent and control it. [ Methods ] patients of AMI with ST-segment elevation were recruited from two Chinese hospitals during 1994-2004. Basic characteristics of each case were documented. Multivariate logistic regression modeling technique was used to explore the risk factors of CS onset after admission. [ Results ] Age, gender, BMI, Killip class, MI location, periphral arterial disease, previous MI, family history of coronary artery disease, and thrombolytic therapy were the 9 important risk factors to shock after AMI. The risk of developing shock in patients with failed thrombolysis or without this therapy was 15 times higher than those with successful thrombolysis. Among patients with failed thrombolysis, 56% had the delays exceeding 12 hours after the onset of AMI, and among those with successful thrombolysis, 41% was administered by thrombolytic agents within 6 hours. [ Conclusion ] The avoidance of CS has been observed when thombolytic therapy is administered as early as possible. The thombolytic therapy is recommended to the third prevention of CS in the elderly Chinese population.
出处 《环境与职业医学》 CAS 北大核心 2007年第3期265-267,共3页 Journal of Environmental and Occupational Medicine
关键词 心源性休克 急性心肌梗死 危险因素 中国人 cardiogenic shock acute myocardial infarction risk factors Chinese
  • 相关文献

参考文献11

  • 1HOLMES D R J, BATES E R, KLEIMAN N S, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-1 Trail experience[ J ]. J Am Coil Cardiol, 1995, 26: 668-674.
  • 2HASDAI D, BERGER P B, BATTER A, et al. Cardiogenic shock [M].NJ: Humana Press, 2002: 35-41.
  • 3HIMBERT D, JULIARD J M, STEG G, et al. Limits of reperfusion therapy for immediate cardiogenic shock complicating acute myocardial infarction[ J ]. Am J Cardiol, 1994, 74: 492--494.
  • 4WALTERS M I, BURN S, HOUGHTON T. Cardiogenic shock: are HEROICS justified [ J ]. Circulation, 1997, 96 Suppl I : 168A.
  • 5HASDAI D, CALIFF R M, THOMPSON TD, et al. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction[ J ]. J Am Coil Cardiol, 2000, 35 : 136-143.
  • 6LATE Study Group. Late assessment of thrombolytic efficacy( LATE ) study with aheplase 6-24 hours after onset of acute myocardial infarction[ J ]. Lancet, 1993, 342: 759-766.
  • 7FTT Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients[ J ]. Lancet, 1994, 343: 311-322.
  • 8LINCOFF A M, TOPOL E J. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction [ J ]. Circulation, 1993, 88: 1361-1374.
  • 9World Health Organization. World Health Statistics Annual, 1993, Geneva[ R ]. Switzerland: World Health Organization, 1994.
  • 10WU Z, YAO C, ZHAO D, et al. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular disease in China, part I: morbidity and mortality monitoring [ J ]. Circulation, 2001, 103: 462--468.

同被引文献37

  • 1张海,方伟敏.心源性休克32例诊治分析[J].中国血液流变学杂志,2005,15(1):53-55. 被引量:2
  • 2林虹,王风,林英忠,王虹,覃丽萍.急性心肌梗死合并心源性休克的预后因素分析[J].医学综述,2006,12(21). 被引量:5
  • 3Hochman JS,Buller CE,Sleeper LA,et al.Cardiogenic shock complicating acute myocardial infarction-etiologies,management and outcome:a report from the SHOCK Trial Registry.Should we erectgently revascularize occluded coronaries for cardiogenic shock[J].J Am Coll Cardiol,2000,36(3 Suppl A):1063.
  • 4Reynolds HR,Hochman JS.Cardiogenic shock:current concepts and improving outcomes[J].Circulation,2008,117(5):686.
  • 5Iakobishvili Z,Behar S,Royko V,et al.Does current treatment of cardiogenie shock comphcating the acute coronary syndromes comply with guidelines[J].Am Heart J,2005,149(1):98.
  • 6Iakobishvili Z,Hasdai D.Cardiogenic shock:treatment[J].Med Clin North Am,2007,91(4):713.
  • 7Migliorini A,Moschi G,Valenti R,et al.Routine percutaneous coronary intervention in elderly patients with cardiogenic shock complicaring acute myocardial infarction[J].Am Heart J,2006,152(5):903.
  • 8Gon SC,Beaver SK,Houck PM,et al.Treatment of acute myocardial infarction and 30-day mortality among women and men[J].N Engl J Med,2000,343(1):8.
  • 9Rieves D,Wright G,Gupta G,et al.Clinical trial (GUSTO-1 and INJECT) evidence of earlier death for men than women after acute myocardial infarction[J].Am J Cardiol,2000,85(2):147.
  • 10Wilson SH,Bell MR,Rihal CS,et al.Infarct artery reocclusion after primary angioplasty,stent placement,and thrombolytic therapy for acute myocardial infarction[J].Am Heart J,2001,141(5):704.

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部